# The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study

> **NCT00407381** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 126 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Ranibizumab
- **PROCEDURE:** Laser photocoagulation

## Key facts

- **NCT ID:** NCT00407381
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2010-08
- **Final completion:** 2011-08
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2017-03-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00407381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00407381, "The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00407381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*